PulseAugur
EN
LIVE 21:46:30
中文(ZH) 药明生物:计划回购至多4亿美元的股票

WuXi Biology plans up to $400M stock buyback

WuXi Biology has announced plans to repurchase up to $400 million of its stock. The company's board of directors approved the buyback, which will be executed on the open market over time. This move comes as spot gold prices have seen a slight decline. AI

IMPACT Company's financial maneuver has minimal direct impact on AI operations.

RANK_REASON Company announces a significant stock repurchase program. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Wuxi Biologics: Plans to repurchase up to $400 million in shares

    36氪获悉,药明生物在港交所发布公告,公司谨此宣布,于二零二六年五月二十四日,其已议决动用购回授权,以及(如适用)股东于本公司股东大会上批准以购回股份的任何未来一般授权,以不时在公开市场上以不超过4亿美元总价格购回股份。